IRIDEX Corp
NASDAQ:IRIX
IRIDEX Corp
Net Income (Common)
IRIDEX Corp
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRIDEX Corp
NASDAQ:IRIX
|
Net Income (Common)
-$9.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is IRIDEX Corp's Net Income (Common)?
Net Income (Common)
-9.6m
USD
Based on the financial report for Dec 30, 2023, IRIDEX Corp's Net Income (Common) amounts to -9.6m USD.
What is IRIDEX Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
6%
Over the last year, the Net Income (Common) growth was -27%. The average annual Net Income (Common) growth rates for IRIDEX Corp have been -15% over the past three years , 6% over the past five years .